EPCAM and acute myeloid leukemia: Having found that Zeb1 deficiency leads to critical impairments in HSC self-renewal, apoptotic, and differentiation fates and because increased EpCAM expression in Zeb1-deficient HSCs enhanced AML signaling, we assessed the role of Zeb1 in AML.